Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry

Translational research has become a priority in every branch of medicine. In psychiatry, it has taken on the goal of advancing our understanding of the neurobiological underpinnings of cognition, behavior, and emotion, and the pathophysiological mechanisms affecting such processes that lead to the development of mental disorders. If successful in identifying objective measures of psychopathology and biomarkers of disease states, translational research will have a tremendous impact on psychiatry, allowing the achievement of a biologically relevant nosology and the development of treatments based on individual characteristics, thus giving rise to the era of personalized treatments (1).